Literature DB >> 18191206

Searching for borrelial T cell epitopes associated with antibiotic-refractory Lyme arthritis.

Elise E Drouin1, Lisa Glickstein, William W Kwok, Gerald T Nepom, Allen C Steere.   

Abstract

Antibiotic-refractory Lyme arthritis is believed to result from an infection-induced autoimmune response triggered by the spirochete Borrelia burgdorferi (Bb). Disease susceptibility is associated with the HLA alleles DRB1*0101, 0401, 0402, 0404, 0405 and DRB5*0101, and all these MHC molecules bind the Bb epitope OspA(163-175.) However, not all patients have a proliferative response to this epitope. To identify other possible Bb epitopes involved in this disease process, the algorithm TEPITOPE was used to scan 17 immunogenic Bb proteins for potential T cell epitopes with a refractory arthritis-associated MHC binding profile, and the Bb proteome was searched for peptides with sequence homology to OspA(165-173). Sixteen promising T epitopes were identified and their MHC binding profiles to 13 MHC molecules were verified using in vitro MHC/peptide binding assays. One peptide, BBK32(392-404), had a strong refractory arthritis-associated MHC binding profile, and another GK(297-306) shared sequence homology to OspA(165-173). However, patient cells did not proliferate in response to either peptide making it highly unlikely they were involved in a refractory course. A comparison of the in silico and in vitro results revealed that TEPITOPE correctly predicted 74% of the in vitro binding peptides, but it incorrectly predicted that 44% of the in vitrononbinding peptides would bind. For a particular MHC molecule, concordance between the in silico and in vitro results varied anywhere between 33% and 100%. Therefore, while additional Bb epitopes may be involved in the development of antibiotic-refractory Lyme arthritis, recognition of OspA(163-175) remains the only known Bb epitope associated with this disease course.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18191206      PMCID: PMC2374920          DOI: 10.1016/j.molimm.2007.11.010

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  30 in total

1.  Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis.

Authors:  D Carlson; J Hernandez; B J Bloom; J Coburn; J M Aversa; A C Steere
Journal:  Arthritis Rheum       Date:  1999-12

Review 2.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

Review 3.  Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?

Authors:  C Benoist; D Mathis
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

Review 4.  The use of bioinformatics for identifying class II-restricted T-cell epitopes.

Authors:  Hongjin Bian; John F Reidhaar-Olson; Juergen Hammer
Journal:  Methods       Date:  2003-03       Impact factor: 3.608

5.  Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis.

Authors:  Priya Kannian; Gail McHugh; Barbara J B Johnson; Rendi M Bacon; Lisa J Glickstein; Allen C Steere
Journal:  Arthritis Rheum       Date:  2007-12

6.  Identification of a promiscuous T-cell epitope in Mycobacterium tuberculosis Mce proteins.

Authors:  Maddalena Panigada; Tiziana Sturniolo; Giorgio Besozzi; Maria Giovanna Boccieri; Francesco Sinigaglia; Giuliana Gialdroni Grassi; Fabio Grassi
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

7.  Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A-reactive T cells.

Authors:  C Trollmo; A L Meyer; A C Steere; D A Hafler; B T Huber
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

8.  Expression of adhesion molecules in synovia of patients with treatment-resistant lyme arthritis.

Authors:  E Akin; J Aversa; A C Steere
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

9.  Recombinant or peptide antigens in the serology of Lyme arthritis in children.

Authors:  Tero Heikkilä; Hans-Iko Huppertz; Ilkka Seppälä; Heidi Sillanpää; Harri Saxen; Pekka Lahdenne
Journal:  J Infect Dis       Date:  2003-06-04       Impact factor: 5.226

10.  Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.

Authors:  Rendi Murphree Bacon; Brad J Biggerstaff; Martin E Schriefer; Robert D Gilmore; Mario T Philipp; Allen C Steere; Gary P Wormser; Adriana R Marques; Barbara J B Johnson
Journal:  J Infect Dis       Date:  2003-04-02       Impact factor: 5.226

View more
  13 in total

Review 1.  MHC class II epitope predictive algorithms.

Authors:  Morten Nielsen; Ole Lund; Søren Buus; Claus Lundegaard
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

2.  Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis.

Authors:  Kathryn L Jones; Gail A McHugh; Lisa J Glickstein; Allen C Steere
Journal:  Arthritis Rheum       Date:  2009-07

3.  Broadly Protective Multivalent OspA Vaccine against Lyme Borreliosis, Developed Based on Surface Shaping of the C-Terminal Fragment.

Authors:  Abhijeet Nayak; Wolfgang Schüler; Stefan Seidel; Ivan Gomez; Andreas Meinke; Pär Comstedt; Urban Lundberg
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

Review 4.  Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis.

Authors:  Allen C Steere; Elise E Drouin; Lisa J Glickstein
Journal:  Clin Infect Dis       Date:  2011-02       Impact factor: 9.079

5.  HLA-DR alleles determine responsiveness to Borrelia burgdorferi antigens in a mouse model of self-perpetuating arthritis.

Authors:  Bettina Panagiota Iliopoulou; Mireia Guerau-de-Arellano; Brigitte T Huber
Journal:  Arthritis Rheum       Date:  2009-12

6.  A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease.

Authors:  Elise E Drouin; Robert J Seward; Klemen Strle; Gail McHugh; Kianoosh Katchar; Diana Londoño; Chunxiang Yao; Catherine E Costello; Allen C Steere
Journal:  Arthritis Rheum       Date:  2013-01

7.  Live Attenuated Borrelia burgdorferi Targeted Mutants in an Infectious Strain Background Protect Mice from Challenge Infection.

Authors:  Beth L Hahn; Lavinia J Padmore; Laura C Ristow; Michael W Curtis; Jenifer Coburn
Journal:  Clin Vaccine Immunol       Date:  2016-08-05

8.  HLA type and immune response to Borrelia burgdorferi outer surface protein a in people in whom arthritis developed after Lyme disease vaccination.

Authors:  Robert Ball; Sean V Shadomy; Abbie Meyer; Brigitte T Huber; Mary S Leffell; Andrea Zachary; Michael Belotto; Eileen Hilton; Marthe Bryant-Genevier; Martin E Schriefer; Frederick W Miller; M Miles Braun
Journal:  Arthritis Rheum       Date:  2009-04

9.  An automated framework for understanding structural variations in the binding grooves of MHC class II molecules.

Authors:  Kalidas Yeturu; Tapani Utriainen; Graham J L Kemp; Nagasuma Chandra
Journal:  BMC Bioinformatics       Date:  2010-01-18       Impact factor: 3.169

Review 10.  Treatment of Lyme borreliosis.

Authors:  Hermann J Girschick; Henner Morbach; Dennis Tappe
Journal:  Arthritis Res Ther       Date:  2009-12-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.